ADAMAS PHARMACEUTICALS INC's ticker is ADMS and the CUSIP is 00548A106. A total of 85 filers reported holding ADAMAS PHARMACEUTICALS INC in Q1 2016. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2018 | $891,000 | +130.2% | 44,500 | +196.7% | 2.13% | +153.5% |
| Q2 2018 | $387,000 | +7.8% | 15,000 | 0.0% | 0.84% | +19.2% |
| Q1 2018 | $359,000 | -64.7% | 15,000 | -50.0% | 0.70% | -20.0% |
| Q4 2017 | $1,017,000 | +60.2% | 30,000 | 0.0% | 0.88% | +54.4% |
| Q3 2017 | $635,000 | +21.0% | 30,000 | 0.0% | 0.57% | +18.5% |
| Q2 2017 | $525,000 | -50.0% | 30,000 | -50.0% | 0.48% | -38.3% |
| Q1 2017 | $1,050,000 | +3.6% | 60,000 | 0.0% | 0.78% | -3.6% |
| Q4 2016 | $1,014,000 | +2.9% | 60,000 | 0.0% | 0.81% | +46.4% |
| Q3 2016 | $985,000 | +44.0% | 60,000 | +32.7% | 0.55% | -16.5% |
| Q2 2016 | $684,000 | -12.4% | 45,198 | -16.3% | 0.66% | +9.4% |
| Q1 2016 | $781,000 | -65.5% | 54,000 | -32.5% | 0.60% | -59.7% |
| Q4 2015 | $2,266,000 | – | 80,000 | – | 1.50% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Stonepine Capital Management, LLC | 751,012 | $3,841,000 | 3.73% |
| Healthcare Value Capital, LLC | 200,000 | $1,023,000 | 1.85% |
| DELTEC ASSET MANAGEMENT LLC | 574,886 | $2,941,000 | 0.74% |
| Kerrisdale Advisers, LLC | 229,347 | $1,173,000 | 0.74% |
| Mosaic Family Wealth, LLC | 91,314 | $609,000 | 0.25% |
| Worth Venture Partners, LLC | 77,384 | $396,000 | 0.23% |
| ARMISTICE CAPITAL, LLC | 536,000 | $2,742,000 | 0.18% |
| EMERALD ADVISERS, LLC | 639,094 | $3,269,000 | 0.15% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 609,019 | $3,115,000 | 0.14% |
| DUDLEY & SHANLEY, INC. | 67,400 | $345,000 | 0.08% |